Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bresotec Medical is a Canadian medical device company focused on the at-home diagnosis of sleep apnea. Its lead product, BresoDX1, is a non-invasive portable home sleep testing system that combines tracheal breath sound and motion sensing with pulse oximetry, wireless data transfer, and software-based analysis to generate diagnostic sleep reports. The company received U.S. FDA 510(k) clearance for BresoDX1 in January 2023 for use in aiding diagnosis of moderate to severe sleep apnea in adults at home. Bresotec appears to be a private, venture-backed spinout from KITE at Toronto Rehab with roots in University of Toronto-affiliated sleep research. Public sources indicate it is focused on commercializing sleep diagnostic technology rather than building a broad therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bresotec Medical.